Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.
Over two million years of life are lost to cancer in the UK every year, according to new research published today in the British Journal of Cancer.
Oct 11, 2023
0
0
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.
Aug 21, 2023
0
49
A new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that some have left a positive legacy that could improve the post-COVID conduct of clinical cancer ...
May 11, 2023
0
2
People with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new research from the University of Surrey and the Office for Health Improvement ...
May 3, 2023
0
11
A new study by researchers at Uppsala University and Uppsala University Hospital shows that men who have a neurodevelopmental disorder, such as autism and ADHD, also have a slightly increased risk of testicular cancer, or ...
Apr 24, 2023
0
26
Predictions are becoming more and more a part of our lives, and they are becoming increasingly useful in medical science as the science evolves. Increased understanding of disease and its treatments allows us to use predictions ...
Apr 13, 2023
0
0
Researchers at the University Hospital Bonn (UKB) have now been able to elucidate a mechanism underlying cisplatin resistance in testicular cancer. Using CRISPR gene scissors, they identified the NAE1 gene as its driver. ...
Apr 11, 2023
0
35
In 2021, 345 women were diagnosed with cervical cancer in Norway, and 79 women died from the disease.
Mar 21, 2023
0
2
The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate ...
Feb 7, 2023
0
2
A team of experts from the University of Barcelona, the University of Zaragoza and Hospital Clínic de Barcelona has found a mechanism of recruitment for tumor-associated cells (cancer-associated fibroblasts or CAFs), which ...
Jan 31, 2023
0
43
